Immune Research Advances Understanding of Autism Spectrum Disorder
A Biological Psychiatry special issue
A Biological Psychiatry special issue
In the Biological Psychiatry special issue “Neuroimmune Mechanisms in Autism Spectrum Disorder”, guest editor Professor Kimberley McAllister of the University of California, Davis, presents five reviews and three original research articles highlighting advances that are transforming the field of autism spectrum disorder (ASD) research.
“ASD is the most rapidly increasing neurodevelopmental disorder and current estimates are alarming,” said Dr. McAllister. One in 68 children and 1 in 42 boys in the US are estimated to be on the spectrum. Few treatment options exist, and the search for effective new therapies has been hindered by a struggle to understand what causes ASD.
“One of the most exciting recent hypotheses in the field is that immune dysregulation contributes to, and may cause, ASD,” Dr. McAllister added. The special issue reports on both environmental factors and genetic mutations that converge on immune dysfunction.
To better understand the neurodevelopmental trajectory and role of immune function in ASD, new clinical studies detail the timing of immunologic disturbances in children with ASD and the relationship between immune system activation and severity of impairments. Inflammation may also help explain why ASD affects boys 4 to 5 times more than girls. A review highlighting the importance of the immune system in the normal development of males proposes how the process of masculinization makes boys more vulnerable to the effects of inflammation.
Children with ASD often suffer from gastrointestinal issues, and two reviews highlight recent research on the environmental and genetic links that may bridge immune dysfunction, the gut microbiome, and impairments in brain development associated with ASD.
Recent research has also implicated the maternal immune system during pregnancy on risk of ASD in children. Two new reviews in the issue collate research in humans and animal models that link alterations in the maternal immune system, whether through genetic autoimmune disorders or through immune system activation in response to infection, with impaired brain development observed in ASD.
“Research in this new area of neuroimmunology provides real hope that new therapies directed at preventing and/or correcting immune dysregulation in ASD could improve the lives of millions of Americans,” Dr. McAllister concluded.
Therapies targeting the immune system may also have benefits beyond ASD, as indicated by a new study linking maternal immune dysfunction with an increased risk of attention-deficit/hyperactivity disorder. The findings suggest that correcting immune dysfunction may have potential for preventing a range of psychiatric diseases.
Copies of this paper included in the special issue are available to credentialed journalists upon request; please contact Elsevier’s Newsroom at email@example.com or +31 20 485 2492.
About Biological Psychiatry
Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders.
The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged.
Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 5th out of 140 Psychiatry titles and 11th out of 256 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2015 Impact Factor score for Biological Psychiatry is 11.212.
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
Editorial Office, Biological Psychiatry
+1 214 648 0880